Market Overview

Benzinga's Top Pre-Market Losers

Related PGNX
Valeant Product Producer Progenics Announce European Approval For RELISTOR To Treat All Opioid Induced Constipation
Earnings Scheduled For March 16, 2015
New indication for Relistor cleared in Europe (Seeking Alpha)
Related SLXP
Benzinga's Volume Movers
US Stock Futures Edge Lower Ahead Of ADP Report

Progenics Pharmaceuticals (NASDAQ: PGNX) shares fell 47.22% to $5.70 in the pre-market trading. Salix Pharmaceuticals Ltd (NASDAQ: SLXP) and Progenics Pharmaceuticals received a Complete Response Letter from the US Food and Drug Administration (FDA) for a Supplemental New Drug Application (sNDA) for RELISTOR.

Salix Pharmaceuticals Ltd (NASDAQ: SLXP) dipped 15.42% to $44.99 in the pre-market session. Analysts at Susquehanna downgraded Salix from “positive” to “neutral.”

Green Mountain Coffee Roasters (NASDAQ: GMCR) moved down 1.88% to $17.70 in the pre-market session. Green Mountain Coffee Roasters shares have dropped 82.65% over the past 52 weeks, while the S&P 500 index has gained 7.25% in the same period.

Masco (NYSE: MAS) dipped 1.58% to $13.09 in the pre-market session. Masco is expected to report its Q2 earnings after the closing bell.

Posted-In: Top Pre-Market LosersNews Movers & Shakers Pre-Market Outlook Markets


Related Articles (GMCR + MAS)

Around the Web, We're Loving...

Get Benzinga's Newsletters